Form 8-K ARS Pharmaceuticals, For: Jul 15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Richard Lowenthal resigns from ARS Pharmaceuticals board
July 17, 2026 4:05 PM EDTRichard Lowenthal resigned from the board of directors of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) on July 15, 2026, effective immediately.
According to a company statement, Lowenthal's resignation was a condition of his right to receive severance compensation under the terms of his employment agreement... More



